The use of enzyme results for liver fibrosis evaluation neccessitates standardization.

Myara A; Guechot J; Lasnier E; Imbert-Bismut F; Voitot H; Ferard G

doi:10.1002/hep.22128

The use of enzyme results for liver fibrosis evaluation neccessitates standardization.

Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H …

MeSH — NLM indexing Alanine Transaminase / blood Alanine Transaminase / standards Aspartate Aminotransferases / blood Aspartate Aminotransferases / standards Biomarkers / blood Humans Liver Cirrhosis / diagnosis

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Letter Our Group France

Authors (6)

Citation

Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H, Ferard G. The use of enzyme results for liver fibrosis evaluation neccessitates standardization. Hepatology. 2008;47(3):1100-1. doi:10.1002/hep.22128.

Identifiers

DOI: 10.1002/hep.22128
PMID: 18266251

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

The use of enzyme results for liver fibrosis evaluation neccessitates standardization.

More on the same topic

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.